Dr. Tarun Tewatia, MD

Dr. Tewatia practices at Holmes Regional Medical Center in Melbourne, Florida, part of Health First.

Dr. Tewatia's NPI, 1285679209, was assigned on June 17, 2006. Dr. Tewatia graduated from Delhi University College of Medical Sciences in 1997. Dr. Tewatia holds Florida license ME94994.

Dr. Tewatia's primary practice is Holmes Regional Medical Center, at 1350 S Hickory St, Melbourne, FL 32901 in Brevard County. The practice phone is (321) 434-7000.

Dr. Tewatia's primary practice is Holmes Regional Medical Center in Melbourne, Florida, part of Health First. Dr. Tewatia is also affiliated with Cape Canaveral Hospital. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Tewatia to 3 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tewatia practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Tewatia's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Tewatia is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Tewatia's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acute diabetes, acute respiratory failure, acute stomach ulcer, anemia, atherosclerosis, cardiac arrhythmia, chest pain and circulation problems among the conditions Dr. Tewatia treats.

CMS data shows 992 Medicare services from Dr. Tewatia across 7 procedure codes in 2024, for 442 Medicare patients. Medicare paid $75,867 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 442 Medicare patients who saw Dr. Tewatia in 2024. The largest group is 75 to 84, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tewatia's median patient age at 73, with 53% women.

In 2024, Dr. Tewatia wrote 748 Medicare Part D claims for 267 patients. 88% of them were for generic drugs. CMS names the drug for 451 of them, across 24 drugs with 11 or more claims each, at $17,712 in total drug cost. In 2023, CMS named 226 claims across 13 drugs.

Dr. Tewatia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Tewatia in 2018. Dr. Tewatia's most frequent co-author is Robert W. Biederman, MD.

CMS Open Payments shows 65 general payments to Dr. Tewatia from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $404.

Dmand AI lists 1 award for Dr. Tewatia, most recently CMS Stage 1 EHR in 2013.

Dr. Tewatia graduated from Delhi University College of Medical Sciences in 1997.

Dr. Tewatia is in network with 7 carriers, including Aetna, United Healthcare and Cigna. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.